Kingfa Science [KINGFA] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

Kingfa Science
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kingfa Science wins in 13 metrics, Grauer & Weil wins in 7 metrics, with 0 ties. Kingfa Science appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Kingfa Science | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 27.68 | 27.77 | Kingfa Science |
Price-to-Book Ratio | 5.83 | 4.65 | Grauer & Weil |
Debt-to-Equity Ratio | 5.90 | 1.26 | Grauer & Weil |
PEG Ratio | 1.12 | 38.69 | Kingfa Science |
EV/EBITDA | 18.95 | 20.47 | Kingfa Science |
Profit Margin (TTM) | 8.58% | 13.85% | Grauer & Weil |
Operating Margin (TTM) | 11.17% | 7.46% | Kingfa Science |
EBITDA Margin (TTM) | 11.17% | 7.46% | Kingfa Science |
Return on Equity | 20.98% | 18.02% | Kingfa Science |
Return on Assets (TTM) | 13.23% | 8.70% | Kingfa Science |
Free Cash Flow (TTM) | $295.94M | $999.80M | Grauer & Weil |
Dividend Yield | 0.32% | 1.05% | Grauer & Weil |
1-Year Return | 20.51% | 1.69% | Kingfa Science |
Price-to-Sales Ratio (TTM) | 2.37 | 3.85 | Kingfa Science |
Enterprise Value | $42.37B | $38.42B | Kingfa Science |
EV/Revenue Ratio | 2.37 | 3.39 | Kingfa Science |
Gross Profit Margin (TTM) | 22.30% | 41.05% | Grauer & Weil |
Revenue per Share (TTM) | $1,478 | $25 | Kingfa Science |
Earnings per Share (Diluted) | $126.79 | $3.47 | Kingfa Science |
Beta (Stock Volatility) | 0.66 | 0.28 | Grauer & Weil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kingfa Science vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Kingfa Science | 0.11% | 6.44% | 5.72% | 12.98% | 25.99% | 5.30% |
Grauer & Weil | -3.24% | 1.00% | -8.63% | 14.99% | 3.51% | -8.98% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Kingfa Science | 20.51% | 247.15% | 607.64% | 1,197.79% | 9,943.64% | 11,623.19% |
Grauer & Weil | 1.69% | 42.58% | 122.46% | 397.91% | 980.68% | 747.59% |
Performance & Financial Health Analysis: Kingfa Science vs Grauer & Weil
Metric | KINGFA | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹42.51B | ₹43.69B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 17,435 | 133,480 |
90 Day Avg. Volume | 14,581 | 191,775 |
Last Close | ₹3,605.40 | ₹92.70 |
52 Week Range | ₹2,550.00 - ₹3,954.00 | ₹78.00 - ₹120.00 |
% from 52W High | -8.82% | -22.75% |
All-Time High | ₹3,954.00 (Jan 06, 2025) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -8.82% | -54.74% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.11% | 0.02% |
Quarterly Earnings Growth | 0.02% | -0.12% |
Financial Health | ||
Profit Margin (TTM) | 0.09% | 0.14% |
Operating Margin (TTM) | 0.11% | 0.07% |
Return on Equity (TTM) | 0.21% | 0.18% |
Debt to Equity (MRQ) | 5.90 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹601.64 | ₹20.72 |
Cash per Share (MRQ) | ₹19.54 | ₹11.87 |
Operating Cash Flow (TTM) | ₹993.76M | ₹1.44B |
Levered Free Cash Flow (TTM) | ₹1.53B | ₹927.08M |
Dividends | ||
Last 12-Month Dividend Yield | 0.32% | 1.05% |
Last 12-Month Dividend | ₹10.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Kingfa Science vs Grauer & Weil
Metric | KINGFA | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 27.68 | 27.77 |
Forward P/E | N/A | 38.69 |
PEG Ratio | 1.12 | 38.69 |
Price to Sales (TTM) | 2.37 | 3.85 |
Price to Book (MRQ) | 5.83 | 4.65 |
Market Capitalization | ||
Market Capitalization | ₹42.51B | ₹43.69B |
Enterprise Value | ₹42.37B | ₹38.42B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.37 | 3.39 |
Enterprise to EBITDA | 18.95 | 20.47 |
Risk & Other Metrics | ||
Beta | 0.66 | 0.28 |
Book Value per Share (MRQ) | ₹601.64 | ₹20.72 |
Financial Statements Comparison: Kingfa Science vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | KINGFA | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹4.70B | ₹3.40B |
Cost of Goods Sold | ₹3.63B | ₹2.00B |
Gross Profit | ₹1.07B | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹905.70M | ₹237.20M |
EBITDA | ₹623.82M | ₹417.40M |
Pre-Tax Income | ₹543.29M | ₹343.50M |
Income Tax | ₹124.31M | ₹86.10M |
Net Income (Profit) | ₹418.98M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | KINGFA | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹234.80M | ₹1.08B |
Total Current Assets | ₹8.54B | ₹9.36B |
Total Current Liabilities | ₹4.22B | ₹2.97B |
Long-Term Debt | ₹20.61M | ₹37.30M |
Total Shareholders Equity | ₹7.29B | ₹9.39B |
Retained Earnings | ₹4.55B | N/A |
Property, Plant & Equipment | ₹2.44B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | KINGFA | GRAUWEIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | KINGFA | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 17,435 | 133,480 |
Average Daily Volume (90 Day) | 14,581 | 191,775 |
Shares Outstanding | 12.11M | 453.41M |
Float Shares | 1.66M | 127.47M |
% Held by Insiders | 0.86% | 0.72% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Kingfa Science vs Grauer & Weil
Metric | KINGFA | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹10.00 | ₹1.00 |
Last 12-Month Dividend Yield | 0.32% | 1.05% |
3-Year Avg Annual Dividend | ₹3.33 | ₹0.58 |
3-Year Avg Dividend Yield | 0.30% | 0.45% |
3-Year Total Dividends | ₹10.00 | ₹1.73 |
Ex-Dividend Date | Sep 17, 2024 | Aug 06, 2025 |